Deletion and down-regulation of SMAD4 gene in colorectal cancers in a Chinese population

被引:6
作者
Ma, Yanling [1 ]
Yan, Fei [1 ]
Li, Li [1 ]
Liu, Li [1 ]
Sun, Jianhai [1 ]
机构
[1] Wuhan Univ, Zhongshan Hosp, Dept Oncol, Wuhan 430033, Peoples R China
关键词
Colorectal cancer (CRC); SMAD4; copy number variation (CNV); gene expression; TGF-BETA; SUSCEPTIBILITY LOCI; PANCREATIC-CANCER; HYPERMETHYLATION; ASSOCIATION; EXPRESSION; 18Q21; MUTATIONS; DPC4;
D O I
10.3978/j.issn.1000-9604.2014.09.02
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Colorectal cancer (CRC) is one of the most common types of human cancers. As a tumor suppressor, SMAD4 plays a key role in colorectal carcinogenesis and invasiveness. Copy number variations (CNVs) of the SMAD4 gene have been reported to be associated with cancer pathogenesis in array-based studies in different populations. Here we aimed to investigate the CNVs of the SMAD4 gene in a relatively large number of CRC patients from China. Methods: In the present study, we collected 147 Chinese CRC tumors as well as self-paired normal control tissues. Quantitative PCR was carried out to examine the copy number as well as the mRNA expression of the SMAD4 gene. Results: Our results showed that the copy number deletions of SMAD4 were frequent in a relatively high percentage of CRC samples (34.7%, 51 out of 147). There was a positive correlation between the copy number decrease of SMAD4 and tumor progression in CRCs. Furthermore, copy number loss of SMAD4 was correlated with decreased mRNA expression. Conclusions: These findings suggested that the copy number deletions of SMAD4 were frequent in CRC patients from China and had the potential to serve as a diagnostic indicator, alone or in combination with other markers, for CRC.
引用
收藏
页码:525 / 531
页数:7
相关论文
共 27 条
  • [1] Loss of p15INK4b Expression in colorectal cancer is Linked to Ethnic Origin
    Abdel-Rahman, Wael Mohamed
    Nieminen, Taina Tuulikki
    Shoman, Soheir
    Eissa, Saad
    Peltomaki, Paivi
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (05) : 2083 - 2087
  • [2] TGF-β signaling in cancer -: a double-edged sword
    Akhurst, RJ
    Derynck, R
    [J]. TRENDS IN CELL BIOLOGY, 2001, 11 (11) : S44 - S51
  • [3] SMAD4 as a prognostic marker in colorectal cancer
    Alazzouzi, H
    Alhopuro, P
    Salovaara, R
    Sammalkorpi, H
    Järvinen, H
    Mecklin, JP
    Hemminki, A
    Schwartz, S
    Aaltonen, LA
    Arango, D
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (07) : 2606 - 2611
  • [4] The 18q21 region in colorectal and pancreatic cancer:: independent loss of DCC and DPC4 expression
    Barberá, VM
    Martín, M
    Mariñoso, L
    Munné, A
    Carrato, A
    Real, FX
    Fabre, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1502 (02): : 283 - 296
  • [5] Prognostic significance of allelic loss at chromosome 18q21 for stage II colorectal cancer
    Carethers, JM
    Hawn, MT
    Greenson, JK
    Hitchcock, CL
    Boland, CR
    [J]. GASTROENTEROLOGY, 1998, 114 (06) : 1188 - 1195
  • [6] Meta Association of Colorectal Cancer Confirms Risk Alleles at 8q24 and 18q21
    Curtin, Karen
    Lin, Wei-Yu
    George, Rina
    Katory, Mark
    Shorto, Jennifer
    Cannon-Albright, Lisa A.
    Bishop, D. Timothy
    Cox, Angela
    Camp, Nicola J.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (02) : 616 - 621
  • [7] Decreased Smad4 expression in the transforming growth factor-β signaling pathway during progression of esophageal squamous cell carcinoma
    Fukuchi, M
    Masuda, N
    Miyazaki, T
    Nakajima, M
    Osawa, H
    Kato, H
    Kuwano, H
    [J]. CANCER, 2002, 95 (04) : 737 - 743
  • [8] Colorectal Cancer Susceptibility Loci in a Population-Based Study Associations with Morphological Parameters
    Ghazi, Sam
    von Holst, Susanna
    Picelli, Simone
    Lindforss, Ulnk
    Tenesa, Albert
    Famngton, Susan M.
    Campbell, Harry
    Dunlop, Malcolm G.
    Papadogiannakis, Nikos
    Lindblom, Annika
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2010, 177 (06) : 2688 - 2693
  • [9] DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
    Hahn, SA
    Schutte, M
    Hoque, ATMS
    Moskaluk, CA
    daCosta, LT
    Rozenblum, E
    Weinstein, CL
    Fischer, A
    Yeo, CJ
    Hruban, RH
    Kern, SE
    [J]. SCIENCE, 1996, 271 (5247) : 350 - 353
  • [10] Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression
    Horvath, LG
    Henshall, SM
    Kench, JG
    Turner, JJ
    Golovsky, D
    Brenner, PC
    O'Neill, GF
    Kooner, R
    Stricker, PD
    Grygiel, JJ
    Sutherland, RL
    [J]. PROSTATE, 2004, 59 (03) : 234 - 242